| Start date | Site | Title | Topic |
---|
ML24176A082 | 17 June 2024 | | Draft Transcript of Meeting of the Advisory Committee on the Uses of Isotopes June 17 2024, Pages 1 - 93 | Brachytherapy |
ENS 57171 | 12 June 2024 21:00:00 | Avera McKennan Hospital | Medical Event - LUTETIUM-177 Misadministration | |
ENS 57135 | 22 May 2024 13:30:00 | Karmanos Cancer Institute | Lost LUTETIUM-177 Source | Moisture Density Gauge |
ML24109A127 | 18 April 2024 | | M240409B: Transcript - Meeting with Advisory Committee on the Medical Uses of Isotopes | Brachytherapy Eye plaque TheraSphere |
ENS 56972 | 1 February 2024 05:00:00 | Hospital Of Fox Chase Cancer Center | Medical Misadministration | |
ML23320A234 | 16 November 2023 | | Ots Chapter 246-221 Wac Standards (002) | High Radiation Area Deep Dose Equivalent Stolen Exclusive Use Overexposure |
ML23318A248 | 23 October 2023 | | ACMUI Fall Transcript | Decommissioning Funding Plan Brachytherapy TheraSphere Overexposure Underdose |
ML23241A933 | 23 August 2023 | | t180-3 Effective 2021-06-15 Highlighted | Safe Shutdown Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Depleted uranium |
SECY-23-0062, Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials | 24 July 2023 | | SECY-23-0062: Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials | Decommissioning Funding Plan Authorized possession limits License Renewal Exemption Request Backfit |
ML23226A087 | 20 July 2023 | | Transcript of Information Meeting with Q&A Sessions on the Proposed Revision to Regulatory Guide 8.39 Release of Patients Administered Radioactive Material, Pages 1-118 | |
ML23122A356 | 30 June 2023 | | Regulatory Basis: Rulemaking on Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere |
ML23166B091 | 14 June 2023 | | Wac Chapter 246-221 Radiation Protection Standards | High Radiation Area Deep Dose Equivalent Stolen Exclusive Use Overexposure |
ML23186A027 | 8 June 2023 | | Emerging Medical Technologies | Brachytherapy |
ML23156A532 | 31 May 2023 | | Alabama Radiation Control Rule, Licensing Rules, Chapter 420-3-2-.02 | Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Stolen Depleted uranium |
ML23187A489 | 15 May 2023 | | Spring 2023 Meeting Official Transcript of Meeting | Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose |
ML23192A046 | 15 May 2023 | | Transcript of Advisory Committee on the Medical Uses of Isotopes, 05/15/2023, Pages 1-227 | Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose |
ML23125A316 | 15 May 2023 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2023 Meeting Handout, May 15, 2023 | Decommissioning Funding Plan Accidental discharge Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose |
NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report | 31 January 2023 | | NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report | Offsite Dose Calculation Manual License Renewal Environmental Justice Depleted uranium |
ML23034A206 | 26 January 2023 | | M230126: Transcript - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines | License Renewal Pandemic COVID-19 |
ML22333B030 | 6 December 2022 | | M221206: Slides - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Brachytherapy TheraSphere |
ML22348A040 | 6 December 2022 | | M221206: Transcript - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Enforcement Discretion Brachytherapy TheraSphere Affidavit |
ML23012A007 | 5 December 2022 | | Transcript of Meeting of the Advisory Committee on Medical Uses of Isotopes (Acmui), December 5, 2022 | Enforcement Discretion Decommissioning Funding Plan Exemption Request Pandemic Brachytherapy TheraSphere |
ML22326A362 | 22 November 2022 | | Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review | Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere |
ENS 56122 | 21 September 2022 05:00:00 | University of Missouri-Columbia | Loss of Radioactive Material in Transit | Moisture Density Gauge |
ML22243A213 | 30 August 2022 | | New Mexico Regulations Title 20 Chapter 3 Part 3 (Amended) | Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Depleted uranium |
ML22136A108 | 31 May 2022 | | Enforcement Program Annual Report, Calendar Year 2021 (Public) | Enforcement Discretion Nondestructive Examination Significance Determination Process Pandemic Coronavirus COVID-19 Moisture Density Gauge |
ML22136A225 | 11 May 2022 | | MD Regulations 26.12.01.01 | Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Uranium Hexafluoride Tritium Sign Exclusive Use Overexposure Depleted uranium |
ML22145A584 | 27 April 2022 | 07007036 | Enclosure 2 - Summary Open Session | |
ML22063A454 | 26 April 2022 | | IP 87130 Nuclear Medicine Programs | |
SECY-19-0125, Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125) | 22 April 2022 | | Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125) | Decommissioning Funding Plan Exemption Request Backfit |
ML22137A323 | 5 April 2022 | | NRC 2022 and ACMUI 2021 Medical Event Summary Presentations | Brachytherapy Eye plaque TheraSphere Overdose Underdose |
ML22179A066 | 5 April 2022 | | Transcript of Meeting of the Advisory Committee on Medical Use of Isotopes, April 5, 2022 | Tritium Exit Sign Decommissioning Funding Plan Pandemic COVID-19 Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose Potassium iodide |
ML22179A159 | 5 April 2022 | | April 5 2022 ACMUI Spring Meeting Transcript_Draft | Tritium Exit Sign Decommissioning Funding Plan Pandemic COVID-19 Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose Potassium iodide |
ML22094A102 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout | Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose |
ML22112A104 | 5 April 2022 | | NRC Staff Medical Event Slide, April 5, 2022, FY21 | Brachytherapy TheraSphere Overdose Underdose |
ML22089A189 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout | Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose |
ML22067A196 | 8 March 2022 | | Washington Regulations Ch 246-232 | License Renewal Depleted uranium |
ML22094A092 | 7 March 2022 | 03002271 03038167 | Washington University in St. Louis - NRC Form 591M Part 1, Inspection Report 03002271/2022001 and 03038167/2022001 | Brachytherapy Eye plaque |
ENS 55766 | 3 March 2022 05:00:00 | Reading Hospital | Agreement State - Underdose | Underdose |
IR 05000186/2021203 | 2 March 2022 | University of Missouri-Columbia | the Curators of the University of Missouri U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000186/2021203 | |
ML22060A212 | 28 February 2022 | | Maryland Regulations 26.12.01.01 | Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Uranium Hexafluoride Tritium Sign Exclusive Use Overexposure Depleted uranium |
ML22026A365 | 26 January 2022 | | CRCPD Part D Draft | High Radiation Area Deep Dose Equivalent Brachytherapy Stolen |
ML22021B299 | 21 January 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39, Release of Patients Administered Radioactive Materials, Review and Comment on the Draft Civaderm Device Licensing Guidance, Final Report, January 21, 2022 | Brachytherapy Eye plaque |
ML22018A078 | 14 January 2022 | | Illinois Regulations Tracked Changes 32-IAC-330 | Static Eliminator Depleted uranium |
ML21341B436 | 15 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout | Brachytherapy Stolen Eye plaque |
ML21341A559 | 1 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comments on the Draft Civaderm Device Licensing Guidance, Draft Report, December 1, 2021 | Brachytherapy Eye plaque |
ML21327A315 | 22 November 2021 | | New Mexico Regulations 20.3.4 | |
ML21330A012 | 31 October 2021 | 07103099 | RAI Response: ISORAD-TC1 Docket No. 71-3099, 10/31/2021, SAR Updates Package (Non-Proprietary) | Nondestructive Examination Finite Element Analysis Liquid penetrant Loctite Exclusive Use Depleted uranium |
ML21301A031 | 25 October 2021 | | Tennessee Regulations 0400-20-10 | Safe Shutdown Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Uranium Hexafluoride Exclusive Use Depleted uranium |
ML21301A025 | 25 October 2021 | | Tennessee Regulations 0400-20-05 | High Radiation Area Deep Dose Equivalent Chernobyl Brachytherapy Stolen Exclusive Use |